Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency of newborns, especially those born prematurely. Mesenchymal stem cell (MSC) therapy has shown efficacy in protection against various forms of tissue injury, and we have demonstrated efficacy in experimental NEC. However, few studies have been performed to establish a safe and effective method of intravenous MSC infusion for newborns. Here we described a safe, non-traumatic, and effective technique for systemic MSC transplantation in newborn rats.
第一作者单位：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Pediat Surg,Wuhan 430074,Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Yang Jixin,Su Yanwei,Besner Gail E..Stem Cell Therapy for Necrotizing Enterocolitis: Innovative Techniques and Procedures for Pediatric Translational Research[J].ANIMAL MODELS FOR STEM CELL THERAPY.2014,1213:121-137.doi:10.1007/978-1-4939-1453-1_11.
APA：
Yang, Jixin,Su, Yanwei&Besner, Gail E..(2014).Stem Cell Therapy for Necrotizing Enterocolitis: Innovative Techniques and Procedures for Pediatric Translational Research.ANIMAL MODELS FOR STEM CELL THERAPY,1213,
MLA：
Yang, Jixin,et al."Stem Cell Therapy for Necrotizing Enterocolitis: Innovative Techniques and Procedures for Pediatric Translational Research".ANIMAL MODELS FOR STEM CELL THERAPY 1213.(2014):121-137
